AzTrials
AzTrials

NormothermiaNCT06597214

Intraoperative Warming: Comparison of Two Temperature Management Systems

A study testing AVACore Technologies, Inc. warmUP Sleeve and Arizant Healthcare Bair Hugger® in people with Normothermia and Intraoperative Temperature, run by Tampa General Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare two temperature management systems, the warmUP (WU-20) and the Bair Hugger®, in preventing perioperative hypothermia during surgeries. The study aims to determine whether the warmUP system is as effective as the Bair Hugger® in maintaining core body temperature. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
AVACore Technologies, Inc. warmUP Sleeve and Arizant Healthcare Bair Hugger®
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteUnited States
Study dates
1 Jun 2023to 15 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects ages 18-80 who are having elective open abdominal surgery from 2-4 hours and requiring general anesthesia.

Who cannot join

  • Patients who are not between ages 18-80
  • Patients who are pregnant; all female patients of childbearing age will be given a pregnancy test on the day of surgery.
  • Patients who have a break in skin integrity on extremity selected as application site
  • Patients who have a history of allergic skin conditions
  • Patients who have a history of bleeding disorders
  • Patients who have a history of malignant hyperthermia

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Tampa General Hospital

    Tampa, Florida, 33606

Other trials in United States

About this study

Official title: Intraoperative Warming: Comparison of Performance of the AVAcore Technologies warmUP™ Temperature Management System (WU-20) and the Arizant Bair Hugger Temperature Management System

The goal of this clinical trial is to compare two temperature management systems, the warmUP (WU-20) and the Bair Hugger®, in preventing perioperative hypothermia during surgeries. The study aims to determine whether the warmUP system is as effective as the Bair Hugger® in maintaining core body temperature.

The main questions this trial aims to answer are:

Read more

Does the warmUP system maintain intraoperative body temperatures as effectively as the Bair Hugger® during abdominal surgeries?

Does the warmUP system offer additional benefits, such as reduced bacterial dispersion compared to the Bair Hugger®?

Participants will:

Use either the warmUP or Bair Hugger® system during surgery Undergo abdominal surgeries lasting approximately 2.5 hours Have their core temperatures monitored to assess the effectiveness of the warming device

The study will evaluate whether the warmUP system provides equivalent temperature management with a smaller body surface area exposed, potentially offering advantages in surgical infection control.

Read the detailed description

Mild perioperative hypothermia (core temperature 34-36ºC) occurs commonly during anesthesia and surgery as a result of a combination of factors: anesthetic induced impairment of thermoregulatory controls, internal redistribution of heat within the body, surgical site skin preparation and subsequent exposure to the 'cold' OR environment. Induction of general anesthesia causes marked changes in the distribution of body heat between the patient's core and periphery. An initial drop in core temperature of between 0.5 to 1.5ºC after induction is the result of internal core-to-periphery redistribution of body heat caused by a combination of anesthesia induced vasodilation and decreased thermoregulatory vasoconstriction. Continued thermal imbalance during anesthesia results from inability of metabolic heat production to overcome the heat loss.

The complications related to mild perioperative hypothermia have been documented in numerous studies and summarized in a 1999 article, "Maintaining intraoperative normothermia: a meta-analysis of outcomes with costs". Complications include reduced resistance to surgical wound infection, reduced platelet function, increased intraoperative loss of blood, increased incidence of ventricular tachycardia and morbid cardiac events, Additionally, the duration of postoperative recovery has also been shown to be prolonged by mild hypothermia.

Various warming methods, such as warm blankets, forced-air warmers and circulating water mattresses, are currently used to prevent and treat mild perioperative hypothermia. All are cutaneous approaches that rely on heating the peripheral tissues in order to increase the thermal core temperature. However, during certain surgical procedures such as laparatomy, a large section of the skin surface (ie., abdomen and part of the patient in contact with the OR table) is unavailable. This can limit the efficacy of methods such as forced-air warming which rely on a large skin surface for heat transfer. Thus, one criterion for an alternative non-invasive warming device is that the heat generated by that device reach its desired target; in the case of perioperative hypothermia, that target is the patient's thermal core.Grahn, et al determined that it would be feasible to combine subatmospheric pressure with a thermal load (heat) and then apply this combination to the body's own specialized heat transfer areas - the ArterioVenous Anastamoses (AVAs) -- found in the hands and the feet. By mechanically distending these specialized heat exchange vessels (the AVAs) through the application of negative pressure, heat can be transferred more efficiently to the body core.

AVAcore Technologies's warmUP (WU-20) Temperature Management System was developed based on work with the Aquarius Medical Acrotherm device (reference 510(k) number: K003368) and prior human hypothermic subject data showing a rewarming rate of ~1ºC in 5 minutes when heat and vacuum application was tested. AVAcore Technologies received FDA acceptance of its Section 510(k) premarket notification for the warmUP (vH1) Temperature Management System in 2005 (reference 510(k) number: K040911). This product was used on over 100 patients in the US in 2005-2006 timeframe.

The warmUP (WU-20) Temperature Management System proposed for use in this study is a minor modification to the vH1 System. The warmUP (WU-20) Temperature Management System is a released product covered with a Letter to File per an assessment based on FDA Guidance documents. The Arizant Healthcare Bair Hugger® Temperature Management System proposed for use in this study is a 'forced air' system providing convective warming via the circulation of warmed air through a specially designed blanket which is placed over a portion of the patient's body. This system has FDA acceptance (reference 510(k) number: K021473.) This product has been in use in the US for over 20 years in a majority of hospitals.

The primary objective is to determine if the AVAcore Technologies warmUP (WU-20) Temperature Management System is as effective as forcedair warming (Bair Hugger™, Arizant Healthcare, Eden Prairie, MN) for maintenance of intraoperative body temperature in patients undergoing abdominal surgery under general anesthesia. The critical endpoints to be evaluated in making this determination are 1) % of subjects with an average intraoperative esophageal temperature of ≥ 36º C and 2) % of subjects with an initial PACU sublingual temperature of ≥ 36º C.

Secondary objectives include 1) comparison of the core body temperatures

@ 60 minutes post anesthesia induction, 2) comparison of temperature trends during surgery and 3) comparison of the subjects' PACU temperature trends and hypothermic symptoms such as shivering.

Being tested
AVACore Technologies, Inc. warmUP Sleeve, Arizant Healthcare Bair Hugger®
Keywords
Forced-air warmers, perioperative temperature management

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AVACore Technologies, Inc. warmUP SleeveDevice

    AVAcore Technologies's warmUP (WU-20) Temperature Management System was developed based on work with the Aquarius Medical Acrotherm device and prior human hypothermic subject data showing a rewarming rate of ~1ºC in 5 minutes when heat and vacuum application was tested. AVAcore Technologies received FDA acceptance of its Section 510(k) premarket notification for the warmUP (vH1) Temperature Management System in 2005. This product was used on over 100 patients in the US in 2005-2006 timeframe.

  • Arizant Healthcare Bair Hugger®Device

    Also called Historical Control Group

    The Arizant Healthcare Bair Hugger® Temperature Management System proposed for use in this study is a 'forced air' system providing convective warming via the circulation of warmed air through a specially designed blanket which is placed over a portion of the patient's body. This product has been in use in the US for over 20 years in a majority of hospitals.

Study groups in NCT06597214
Study groupRoleWhat they receive
AVACore Technologies, Inc. warmUP SleeveExperimentalAVAcore Technologies's warmUP (WU-20) Temperature Management System was developed based on work with the Aquarius Medical Acrotherm device and prior human hypothermic subject data showing a rewarming rate of ~1ºC in 5 minutes when heat and vacuum application was tested. AVAcore Technologies received FDA acceptance of its Section 510(k) premarket notification for the warmUP (vH1) Temperature Management System in 2005. This product was used on over 100 patients in the US in 2005-2006 timeframe.
Receives: Device: AVACore Technologies, Inc. warmUP Sleeve; Device: Arizant Healthcare Bair Hugger®

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Initial Temperature

    Comparison of body temperature

    Measured: 60 minutes after induction of general anesthesia]

  2. Continuing Temperature trends

    Comparison of body temperature throughout surgery

    Measured: Recorded every 15 minutes from the start of administration of general anesthesia through end of administration of anesthesia; typically 4-5 hours.

  3. Post-operative temperature

    Taking patient temperature whilst in recovery in the post-anesthesia care unit (PACU)

    Measured: 5 minutes after PACU admission

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start1 Jun 2023
  3. Primary completion15 May 2025
  4. Study completion15 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
Prospective single-group assignment compared to a standard control.
Masking
None (open label)
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06597214
Sponsor's protocol ID
STUDY001814 Sleeve Blanket
Status last verified
Jun 2025
First submitted
6 Sep 2024
Last updated
25 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Sessler DI. Mild perioperative hypothermia. N Engl J Med. 1997 Jun 12;336(24):1730-7. doi: 10.1056/NEJM199706123362407. No abstract available.

    PubMed 9180091
  • Davis AJ, Bissonnette B. Thermal regulation and mild intraoperative hypothermia. Curr Opin Anaesthesiol. 1999 Jun;12(3):303-9. doi: 10.1097/00001503-199906000-00008.

    PubMed 17013328
  • Sessler DI. Perioperative heat balance. Anesthesiology. 2000 Feb;92(2):578-96. doi: 10.1097/00000542-200002000-00042.

    PubMed 10691247

Questions about this trial

What is this clinical trial studying?

A study testing AVACore Technologies, Inc. warmUP Sleeve and Arizant Healthcare Bair Hugger® in people with Normothermia and Intraoperative Temperature, run by Tampa General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Initial Temperature (time frame: 60 minutes after induction of general anesthesia]). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06597214, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in